全文获取类型
收费全文 | 1318篇 |
免费 | 61篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 37篇 |
妇产科学 | 22篇 |
基础医学 | 142篇 |
口腔科学 | 22篇 |
临床医学 | 183篇 |
内科学 | 358篇 |
皮肤病学 | 32篇 |
神经病学 | 132篇 |
特种医学 | 145篇 |
外科学 | 97篇 |
综合类 | 25篇 |
预防医学 | 67篇 |
眼科学 | 5篇 |
药学 | 67篇 |
1篇 | |
中国医学 | 3篇 |
肿瘤学 | 39篇 |
出版年
2023年 | 5篇 |
2022年 | 7篇 |
2021年 | 7篇 |
2020年 | 5篇 |
2019年 | 11篇 |
2018年 | 15篇 |
2017年 | 12篇 |
2016年 | 13篇 |
2015年 | 20篇 |
2014年 | 22篇 |
2013年 | 31篇 |
2012年 | 38篇 |
2011年 | 47篇 |
2010年 | 44篇 |
2009年 | 45篇 |
2008年 | 43篇 |
2007年 | 53篇 |
2006年 | 57篇 |
2005年 | 65篇 |
2004年 | 49篇 |
2003年 | 51篇 |
2002年 | 49篇 |
2001年 | 42篇 |
2000年 | 49篇 |
1999年 | 35篇 |
1998年 | 47篇 |
1997年 | 52篇 |
1996年 | 48篇 |
1995年 | 29篇 |
1994年 | 38篇 |
1993年 | 26篇 |
1992年 | 24篇 |
1991年 | 22篇 |
1990年 | 27篇 |
1989年 | 37篇 |
1988年 | 39篇 |
1987年 | 29篇 |
1986年 | 16篇 |
1985年 | 17篇 |
1984年 | 23篇 |
1983年 | 18篇 |
1982年 | 15篇 |
1981年 | 15篇 |
1980年 | 7篇 |
1979年 | 5篇 |
1978年 | 8篇 |
1977年 | 3篇 |
1976年 | 5篇 |
1969年 | 4篇 |
1965年 | 2篇 |
排序方式: 共有1384条查询结果,搜索用时 0 毫秒
81.
Boccardi M Laakso MP Bresciani L Geroldi C Beltramello A Frisoni GB 《European archives of psychiatry and clinical neuroscience》2002,252(5):235-239
In this paper we explored patterns of frontal and temporal asymmetry in frontotemporal dementia (FTD) and tried to isolate
clinical correlates associated with asymmetry or lack thereof. Volumes of frontal and temporal lobes, hippocampus and entorhinal
cortex were measured using magnetic resonance imaging (MRI) in 10 patients with FTD. Age- and cranial size-specific values
were computed through linear regression analysis (W-scores). A subgroup of 3 patients with symmetric frontal and temporal
atrophy was identified. When compared to patients with asymmetric atrophy, the former had younger age at onset of the disease
(p = 0.02), greater overall frontotemporal (p = 0.02) and greater entorhinal atrophy (p < 0.04). Two of the three patients
were apolipoprotein E ɛ4 carriers versus none of the asymmetric patients (p = 0.02). The lack of asymmetry in this small sample
of FTD patients was associated with greater brain atrophy, younger age at onset, and presence of the ɛ4 allele of apolipoprotein
E. The presence of the ɛ4 allele is consistent with the hypothesis of greater vulnerability of the brain in ɛ4 carriers.
Received: 15 April 2002 / Accepted: 2 October 2002
Correspondence to Dr. G. B. Frisoni 相似文献
82.
83.
Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease 总被引:26,自引:2,他引:24 下载免费PDF全文
Du AT Schuff N Amend D Laakso MP Hsu YY Jagust WJ Yaffe K Kramer JH Reed B Norman D Chui HC Weiner MW 《Journal of neurology, neurosurgery, and psychiatry》2001,71(4):441-447
OBJECTIVES: To explore volume changes of the entorhinal cortex (ERC) and hippocampus in mild cognitive impairment (MCI) and Alzheimer's disease (AD) compared with normal cognition (NC); to determine the powers of the ERC and the hippocampus for discrimination between these groups. METHODS: This study included 40 subjects with NC, 36 patients with MCI, and 29 patients with AD. Volumes of the ERC and hippocampus were manually measured based on coronal T1 weighted MR images. Global cerebral changes were assessed using semiautomatic image segmentation. RESULTS: Both ERC and hippocampal volumes were reduced in MCI (ERC 13%, hippocampus 11%, p<0.05) and AD (ERC 39%, hippocampus 27%, p<0.01) compared with NC. Furthermore, AD showed greater volume losses in the ERC than in the hippocampus (p<0.01). In addition, AD and MCI also had cortical grey matter loss (p< 0.01) and ventricular enlargement (p<0.01) when compared with NC. There was a significant correlation between ERC and hippocampal volumes in MCI and AD (both p<0.001), but not in NC. Using ERC and hippocampus together improved discrimination between AD and CN but did not improve discrimination between MCI and NC. The ERC was better than the hippocampus for distinguishing MCI from AD. In addition, loss of cortical grey matter significantly contributed to the hippocampus for discriminating MCI and AD from NC. CONCLUSIONS: Volume reductions in the ERC and hippocampus may be early signs of AD pathology that can be measured using MRI. 相似文献
84.
85.
86.
The 131-I-triiodothyronine-resin uptake test during labour 总被引:1,自引:0,他引:1
87.
88.
89.
The leptin receptor (OB-R) gene is a promising candidate gene for type 2 diabetes, because leptin and its receptor play an important role in insulin secretion and the development of obesity. Therefore, we studied whether the pentanucleotide insertion polymorphism of the 3'-untranslated region (3'UTR) of the OB-R gene has an influence on the conversion from impaired glucose tolerance (IGT) to type 2 diabetes in the STOP-Noninsulin-Dependent Diabetes Mellitus trial. The STOP trial was a longitudinal, double-blind, placebo-controlled randomized trial that included 1429 subjects with IGT from high-risk populations. Using the restriction fragment length polymorphism method, we genotyped 770 subjects whose DNA was available for the insertion/deletion polymorphism of the 3'UTR of the OB-R gene. We did not find a relationship between the OB-R polymorphism and the conversion from IGT to type 2 diabetes (p = 0.747). However, the insertion allele was associated with a significant reduction in weight (p = 0.016), BMI (p = 0.009), and waist circumference (p = 0.006) in all subjects. Women carrying the I allele had a larger waist circumference change (p = 0.036), whereas men lost more weight and had a greater decrease in BMI. The pentanucleotide insertion/deletion polymorphism in the 3'UTR of the OB-R gene did not influence the conversion to type 2 diabetes in obese patients with IGT. However, this polymorphism was associated with a significant weight change, suggesting that it may potentially modulate the risk for type 2 diabetes. 相似文献
90.
Adiponectin is an adipose tissue-specific protein with insulin-sensitizing and antiatherogenic properties. Therefore, the adiponectin gene is a promising candidate gene for type 2 diabetes. We investigated the single nucleotide polymorphisms (SNPs) +45T/G and +276G/T of the adiponectin gene as predictors for the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial, which aimed to investigate the effect of acarbose compared with placebo on the prevention of type 2 diabetes. Compared with the TT genotype, the G-allele of SNP +45 was associated with a 1.8-fold risk for type 2 diabetes (95% CI 1.12-3.00, P = 0.015) in the placebo group. Subjects treated with placebo and simultaneously having the G-allele of SNP +45 and the T-allele of SNP +276 (the risk genotype combination) had a 4.5-fold (1.78-11.3, P = 0.001) higher risk of developing type 2 diabetes compared with subjects carrying neither of these alleles. Women carrying the risk genotype combination had an especially high risk of conversion to diabetes (odds ratio 22.2, 95% CI 2.7-183.3, P = 0.004). In conclusion, the G-allele of SNP +45 is a predictor for the conversion to type 2 diabetes. Furthermore, the combined effect of SNP +45 and SNP +276 on the development of type 2 diabetes was stronger than that of each SNP alone. 相似文献